Divinopolis City Hall, through the Immunization Center of the Municipal Health Administration (SIMOSA), announces that vaccination against dengue will continue in health units and cover children and adolescents aged 10 to 14 years.
The municipality will receive 12,729 doses of dengue vaccines, with the first shipment containing 3,182 doses, with nearly 800 doses applied in a joint effort last Saturday (04/05).
Vaccination takes place in health units from 8 a.m. to 4 p.m. Units that have a 24-hour health program (Afonso Pena, Bom Pasteur, Ermida, Ipiranga, Niteroi, Sagrada Familia, Planalto, Belvedere, Tete and Nossa Senhora das Grasas), vaccination from 8 am to 4 pm and from 6 pm to 21 hours.
Deputy Mayor and Secretary to the Government Janet Aparecida asks everyone to look for health facilities: “I explain that the vaccine is free and adherence to it is voluntary, but it is very important in the fight against the virus infection transmitted by this insect that makes people sick.” There are a lot of people, but I ask residents to maintain necessary precautions to prevent the spread of mosquitoes.”
It is important to highlight that the dengue immunization process is divided into two doses and is therefore administered at an interval of at least 3 months. To be vaccinated, a teenager must have a CPF document or SUS card, vaccination card and must be accompanied by a parent or guardian and stay in the unit for 15 minutes.
Important recommendations
– Dengue vaccine cannot be given simultaneously with other vaccines. If children are vaccinated with vaccines made up of inactivated viruses, such as influenza, the dengue vaccine can only be given at least 24 hours apart.
– For vaccines containing attenuated viruses, such as MMR and yellow fever, the recommended interval is 30 days from dengue vaccination.
– Regarding infection with dengue virus. People who have been infected with the dengue virus should wait 6 months to begin a vaccination schedule with the dengue (attenuated) vaccine.
contraindications
Dengue vaccine should not be given in the following cases:
• Anaphylaxis or allergic reaction to any component of the vaccine or to the previous dose of that vaccine.
• Individuals with congenital or acquired immunodeficiency, including those receiving immunosuppressive treatments such as chemotherapy or high doses of systemic corticosteroids within four weeks before vaccination, as with other live attenuated vaccines.
• Individuals with symptomatic or asymptomatic HIV infection when accompanied by evidence of impaired immune function.
Negative feedback
The most common adverse reactions are reactions at the vaccine application site with pain, redness and edema. Systemic reactions such as fever, headache, myalgia, weakness, and loss of appetite may also occur. Rare reactions have included irritability (in children), allergic reactions, and drowsiness.
“Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast.”
